Position Article and Guidelines
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
The standard of care for most patients with non-muscle-invasive bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Guérin (BCG), which activates the immune system to recognize and dest...
Journal for ImmunoTherapy of Cancer 2017 5:68
Published on: 15 August 2017